Nektar Therapeutics NKTR Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's deferred tax assets and other non-current assets?
- Nektar Therapeutics (NKTR) reported deferred tax assets and other non-current assets of $11.24M in Q1 2026.
- How has Nektar Therapeutics's deferred tax assets and other non-current assets changed year-over-year?
- Nektar Therapeutics's deferred tax assets and other non-current assets increased by 108.4% year-over-year, from $5.39M to $11.24M.
- What is the long-term trend for Nektar Therapeutics's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Nektar Therapeutics's deferred tax assets and other non-current assets has grown at a 57.5% compound annual growth rate (CAGR), from $1.46M to $14.14M.